Finance

Beta
Lists
MANGALAM:NSE
Mangalam Drugs and Organics Ltd
₹28.31
+0.25%
(+0.070) 1D
Jun 4, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for MANGALAM...
Open
₹28.24
High
₹29.22
Low
₹27.77
Mkt. cap
448.10M
Avg. vol.
18.93K
Volume
13.71K
52-wk high
₹95.00
52-wk low
₹22.80
EPS
-₹28.05
Shares outstanding
15.83M
No. of employees
480
Open
₹28.24
High
₹29.22
Low
₹27.77
Mkt. cap
448.10M
Avg. vol.
18.93K
Volume
13.71K
52-wk high
₹95.00
52-wk low
₹22.80
EPS
-₹28.05
Shares outstanding
15.83M
No. of employees
480
News stories
From sources across the web
About Mangalam Drugs and Organics Ltd
CEO-
Employees480
Founded1972
Headquarters-
SectorPharmaceutical industry
Websitemangalamdrugs.com
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
572.09M
492.60M
583.76M
672.87M
Cost of goods sold
395.79M
330.60M
370.74M
471.62M
Cost of revenue
395.79M
330.60M
370.74M
471.62M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
93.81M
75.33M
102.64M
84.87M
Operating expense
265.84M
236.67M
271.95M
303.14M
Total operating expenses
661.63M
567.27M
642.69M
774.76M
Operating income
-89.54M
-74.66M
-58.93M
-101.89M
Other non operating income
4.00K
278.00K
1.11M
-
EBT including unusual items
-129.98M
-124.67M
-98.35M
-132.71M
EBT excluding unusual items
-129.98M
-124.67M
-98.35M
-132.71M
Income tax expense
8.00M
-51.20M
5.00K
1.49M
Effective tax rate
-6.15%
41.07%
-0.01%
-1.12%
Other operating expenses
127.27M
115.06M
124.69M
171.68M
Net income
-137.98M
-73.46M
-98.36M
-134.20M
Net profit margin
-24.12%
-14.91%
-16.85%
-19.94%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-40.45M
-50.28M
-40.53M
-30.82M
Net interest expenses
-40.45M
-50.28M
-40.53M
-30.82M
Depreciation and amortization charges
44.76M
46.29M
44.61M
46.58M
EBITDA
-48.02M
-29.14M
-25.28M
-56.33M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer